Recombinant Human FGF-9

Recombinant Human FGF-9

Size1:10μg price1:$100
Size2:50μg price2:$299
SKU: PCH2509 Category: Cytokines Tags: ,

Datasheet

Name

Recombinant Human FGF-10/KGF2

Purity

Greater than 98% as determined by reducing SDS-PAGE

Endotoxin level

≤10 EU/mg

Construction

Recombinant Human FGF-10/KGF2 is produced by our Mammalian cell expression system and the target gene encoding Gln38-Ser208 is expressed.

Accession #

O15520

Host

Human Cells

Species

Human

Predicted Molecular Mass

19.3 kDa

Buffer

Lyophilized From PBS,5% mannitol and 0.01% Tween 80, pH7.4

Form

Shipping

The product is shipped on dry ice/polar packs.Upon receipt, store it immediately at the temperature listed below.

Stability&Storage

Store at ≤-70°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles.

Reconstitution

Always centrifuge tubes before opening.Do not mix by vortex or pipetting.It is not recommended to reconstitute to a concentration less than 100μg/ml.Dissolve the lyophilized protein in distilled water.Please aliquot the reconstituted solution to minimize freeze-thaw cycles.

 

 

 

Alternative Names

Fibroblast growth factor 10;FGF-10;Keratinocyte growth factor 2;FGF10;KGF-2;KGF2

 

Background

Fibroblast growth factor 10 (FGF-10, KGF-2), is a member of the fibroblast growth factor (FGF) family that includes FGF-3, -7, and -22. KGF-2 is secreted by mesenchymal cells and associates with extracellular FGF-BP. It preferentially binds and activates epithelial cell FGFR2 and interacts more weakly with FGFR1. It plays an important role in the regulation of embryonic development, cell proliferation and cell differentiation. It exhibits mitogenic activity for keratinizing epidermal cells, but essentially no activity for fibroblasts, which is similar to the biological activity of FGF7. FGF10 is required for normal branching morphogenesis. Defects in FGF10 are the cause of autosomal dominant aplasia of lacrimal and salivary glands (ALSG). ALSG has variable expressivity, and affected individuals may have aplasia or hypoplasia of the lacrimal, parotid, submandibular and sublingual glands and absence of the lacrimal puncta. The disorder is characterized by irritable eyes, recurrent eye infections, epiphora (constant tearing) and xerostomia (dryness of the mouth), which increases the risk of dental erosion, dental caries, periodontal disease and oral infections.

 

Note

For Research Use Only , Not for Diagnostic Use.